• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

格雷夫斯病的外科治疗结果:单中心216例经验

Outcomes of Surgical Treatment for Graves' Disease: A Single-Center Experience of 216 Cases.

作者信息

Sun Hanxing, Tong Hui, Shen Xiaohui, Gao Haoji, Kuang Jie, Chen Xi, Li Qinyu, Qiu Weihua, Liu Zhuoran, Yan Jiqi

机构信息

Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

出版信息

J Clin Med. 2023 Feb 7;12(4):1308. doi: 10.3390/jcm12041308.

DOI:10.3390/jcm12041308
PMID:36835843
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9968166/
Abstract

BACKGROUND

The role of surgery in the treatment of Graves' disease (GD) needs to be revisited. The aims of the present retrospective study were to evaluate the outcomes of the current surgical strategy as a definitive treatment of GD at our center and to explore the clinical association between GD and thyroid cancer.

METHODS

A patient cohort of 216 cases from 2013 to 2020 was involved in this retrospective study. The data of the clinical characteristics and follow-up results were collected and analyzed.

RESULTS

There were 182 female and 34 male patients. The mean age was 43.9 ± 15.0 years old. The mean duration of GD reached 72.2 ± 92.7 months. Of the 216 cases, 211 had been treated with antithyroid drugs (ATDs) and hyperthyroidism had been completely controlled in 198 cases. A total (75%) or near-total (23.6%) thyroidectomy was performed. Intraoperative neural monitoring (IONM) was applied to 37 patients. The failure of ATD therapy (52.3%) was the most common surgical indication, followed by suspicion of a malignant nodule (45.8%). A total of 24 (11.1%) patients had hoarseness after the operation and 15 (6.9%) patients had transient vocal cord paralysis; 3 (1.4%) had this problem permanently. No bilateral RLN paralysis occurred. A total of 45 patients had hypoparathyroidism and 42 of them recovered within 6 months. Sex showed a correlation with hypoparathyroidism through a univariate analysis. A total of 2 (0.9%) patients underwent a reoperation because of hematomas. A total of 104 (48.1%) cases were diagnosed as thyroid cancer. In most cases (72.1%), the malignant nodules were microcarcinomas. A total of 38 patients had a central compartment node metastasis. A lateral lymph node metastasis occurred in 10 patients. Thyroid carcinomas were incidentally discovered in the specimens of 7 cases. The patients with concomitant thyroid cancer had a significant difference in body mass index, duration of GD, gland size, thyrotropin receptor antibodies and nodule(s) detected.

CONCLUSION

Surgical treatments for GD were effective, with a relatively low incidence of complications at this high-volume center. Concomitant thyroid cancer is one of the most important surgical indications for GD patients. Careful ultrasonic screening is necessary to exclude the presence of malignancies and to determine the therapeutic plan.

摘要

背景

需要重新审视手术在格雷夫斯病(GD)治疗中的作用。本回顾性研究的目的是评估当前手术策略作为我院GD确定性治疗方法的效果,并探讨GD与甲状腺癌之间的临床关联。

方法

本回顾性研究纳入了2013年至2020年的216例患者队列。收集并分析了临床特征和随访结果的数据。

结果

女性患者182例,男性患者34例。平均年龄为43.9±15.0岁。GD的平均病程达72.2±92.7个月。216例患者中,211例曾接受抗甲状腺药物(ATD)治疗,198例患者的甲亢得到完全控制。共进行了全甲状腺切除术(75%)或近全甲状腺切除术(23.6%)。37例患者术中应用了神经监测(IONM)。ATD治疗失败(52.3%)是最常见的手术指征,其次是怀疑恶性结节(45.8%)。共有24例(11.1%)患者术后出现声音嘶哑,15例(6.9%)患者出现短暂性声带麻痹;3例(1.4%)患者永久性出现该问题。未发生双侧喉返神经麻痹。共有45例患者发生甲状旁腺功能减退,其中42例在6个月内恢复。单因素分析显示性别与甲状旁腺功能减退相关。共有2例(0.9%)患者因血肿接受了再次手术。共有104例(48.1%)病例被诊断为甲状腺癌。在大多数病例(72.1%)中,恶性结节为微小癌。共有38例患者发生中央区淋巴结转移。10例患者发生侧方淋巴结转移。7例患者的标本中偶然发现甲状腺癌。合并甲状腺癌的患者在体重指数、GD病程、腺体大小、促甲状腺素受体抗体及检测到的结节方面存在显著差异。

结论

在这个大型中心,GD的手术治疗是有效的,并发症发生率相对较低。合并甲状腺癌是GD患者最重要的手术指征之一。需要仔细进行超声筛查以排除恶性肿瘤的存在并确定治疗方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad74/9968166/07378d68d260/jcm-12-01308-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad74/9968166/e320bbee413f/jcm-12-01308-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad74/9968166/273c5fb02861/jcm-12-01308-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad74/9968166/07378d68d260/jcm-12-01308-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad74/9968166/e320bbee413f/jcm-12-01308-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad74/9968166/273c5fb02861/jcm-12-01308-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad74/9968166/07378d68d260/jcm-12-01308-g003.jpg

相似文献

1
Outcomes of Surgical Treatment for Graves' Disease: A Single-Center Experience of 216 Cases.格雷夫斯病的外科治疗结果:单中心216例经验
J Clin Med. 2023 Feb 7;12(4):1308. doi: 10.3390/jcm12041308.
2
Safety and efficacy of surgical management of hyperthyroidism: 15-year experience from a tertiary care center in a developing country.甲状腺功能亢进症手术治疗的安全性和有效性:来自一个发展中国家三级医疗中心的15年经验。
World J Surg. 2007 Feb;31(2):306-12; discussion 313. doi: 10.1007/s00268-006-0572-9.
3
Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.经单侧耳后入路机器人辅助全甲状腺切除术并改良根治性颈清扫术
Ann Surg Oncol. 2014 Nov;21(12):3872-5. doi: 10.1245/s10434-014-3896-y. Epub 2014 Sep 17.
4
Prevalence and aggressiveness of papillary thyroid carcinoma in surgically-treated graves' disease patients: a retrospective matched cohort study.在接受手术治疗的格雷夫斯病患者中,甲状腺乳头状癌的患病率和侵袭性:一项回顾性匹配队列研究。
J Otolaryngol Head Neck Surg. 2019 Aug 28;48(1):40. doi: 10.1186/s40463-019-0364-5.
5
Thyroid Cancer and Nodules in Graves' Disease: A Single Center Experience.格雷夫斯病中的甲状腺癌与结节:单中心经验
Endocr Metab Immune Disord Drug Targets. 2021;21(11):2028-2034. doi: 10.2174/1871530321666201230111911.
6
Impaired Quality of Life After Radioiodine Therapy Compared to Antithyroid Drugs or Surgical Treatment for Graves' Hyperthyroidism: A Long-Term Follow-Up with the Thyroid-Related Patient-Reported Outcome Questionnaire and 36-Item Short Form Health Status Survey.放射性碘治疗后生活质量受损与 Graves 甲亢的抗甲状腺药物或手术治疗相比:使用甲状腺相关患者报告结局问卷和 36 项简明健康状况调查问卷的长期随访。
Thyroid. 2019 Mar;29(3):322-331. doi: 10.1089/thy.2018.0315.
7
Risk Factors for the Relapse of Graves' Disease Treated With Antithyroid Drugs: A Systematic Review and Meta-analysis.抗甲状腺药物治疗 Graves 病复发的危险因素:系统评价和荟萃分析。
Clin Ther. 2020 Apr;42(4):662-675.e4. doi: 10.1016/j.clinthera.2020.01.022. Epub 2020 Mar 2.
8
Thyroid Doppler ultrasonography and resistive index in the evaluation of the need for ablative or antithyroid drug therapy in Graves' hyperthyroidism.甲状腺多普勒超声检查及阻力指数在评估格雷夫斯甲亢患者是否需要进行消融治疗或抗甲状腺药物治疗中的应用
J Formos Med Assoc. 2001 Nov;100(11):753-7.
9
Features and outcome of differentiated thyroid carcinoma associated with Graves' disease: results of a large, retrospective, multicenter study.与格雷夫斯病相关的分化型甲状腺癌的特征和结局:一项大型回顾性多中心研究的结果。
J Endocrinol Invest. 2020 Jan;43(1):109-116. doi: 10.1007/s40618-019-01088-5. Epub 2019 Jul 20.
10
Surgical management of pediatric thyroid disease: Complication rates after thyroidectomy at the Children's Hospital of Philadelphia high-volume Pediatric Thyroid Center.小儿甲状腺疾病的外科治疗:费城儿童医院大容量小儿甲状腺中心甲状腺切除术的并发症发生率。
J Pediatr Surg. 2019 Oct;54(10):1969-1975. doi: 10.1016/j.jpedsurg.2019.02.009. Epub 2019 Feb 28.

引用本文的文献

1
Overweight as a biomarker for concomitant thyroid cancer in patients with Graves' disease.超重作为 Graves 病患者合并甲状腺癌的生物标志物。
Front Endocrinol (Lausanne). 2024 Apr 22;15:1382124. doi: 10.3389/fendo.2024.1382124. eCollection 2024.

本文引用的文献

1
Thyroid-Stimulating Hormone, Age, and Tumor Size are Risk Factors for Progression During Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma in Adults.促甲状腺激素、年龄和肿瘤大小是成人低危甲状腺微小乳头状癌主动监测期间进展的危险因素。
World J Surg. 2023 Feb;47(2):392-401. doi: 10.1007/s00268-022-06770-z. Epub 2022 Oct 2.
2
Revisiting the role of surgery in the treatment of Graves' disease.重新审视手术在 Graves 病治疗中的作用。
Clin Endocrinol (Oxf). 2022 Jun;96(6):747-757. doi: 10.1111/cen.14653. Epub 2021 Dec 26.
3
Clinical Characteristics and Prognosis of Coexisting Thyroid Cancer in Patients with Graves' Disease: A Retrospective Multicenter Study.
Graves 病合并甲状腺癌患者的临床特征和预后:一项回顾性多中心研究。
Endocrinol Metab (Seoul). 2021 Dec;36(6):1268-1276. doi: 10.3803/EnM.2021.1227. Epub 2021 Nov 26.
4
Thyroidectomy for Graves' Disease Predicts Postoperative Neck Hematoma and Hypocalcemia: A North American cohort study.甲状腺切除术治疗格雷夫斯病可预测术后颈部血肿和低钙血症:一项北美队列研究。
Ann Otol Rhinol Laryngol. 2022 Apr;131(4):341-351. doi: 10.1177/00034894211021288. Epub 2021 Jun 1.
5
Outcomes of Graves' Disease Patients Following Antithyroid Drugs, Radioactive Iodine, or Thyroidectomy as the First-line Treatment.一线治疗为抗甲状腺药物、放射性碘或甲状腺切除术的 Graves 病患者的结局。
Ann Surg. 2021 Jun 1;273(6):1197-1206. doi: 10.1097/SLA.0000000000004828.
6
Thyroid Cancer and Nodules in Graves' Disease: A Single Center Experience.格雷夫斯病中的甲状腺癌与结节:单中心经验
Endocr Metab Immune Disord Drug Targets. 2021;21(11):2028-2034. doi: 10.2174/1871530321666201230111911.
7
Short-Term Outcomes of Surgery for Graves' Disease in Germany.德国格雷夫斯病手术的短期疗效
J Clin Med. 2020 Dec 11;9(12):4014. doi: 10.3390/jcm9124014.
8
Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma.成人低危甲状腺微小乳头状癌主动监测的适应证和策略:日本内分泌外科学会甲状腺微小乳头状癌管理工作组的共识声明。
Thyroid. 2021 Feb;31(2):183-192. doi: 10.1089/thy.2020.0330. Epub 2020 Nov 2.
9
Graves' disease.格雷夫斯病。
Nat Rev Dis Primers. 2020 Jul 2;6(1):52. doi: 10.1038/s41572-020-0184-y.
10
Graves' disease insights from a review of the Johns Hopkins surgical pathology archive.通过回顾约翰·霍普金斯手术病理档案对格雷夫斯病的见解。
J Endocrinol Invest. 2020 Oct;43(10):1519-1522. doi: 10.1007/s40618-020-01232-6. Epub 2020 Apr 11.